An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Ardeshir states, "This new hypothesis could help protect newborns in high-risk areas during the most vulnerable period of ...

HIV drugs offer ‘substantial’ Alzheimer’s protection, new research indicates (IMAGE) ...

Research Assistant Daniel O'Hagan works in the lab alongside Associate Professor Mauricio Martins, Ph.D., at The Wertheim UF ...

Research suggests sickle cell anemia may offer some protection against HIV and may also slow HIV progression. However, experts still need further research to understand why this occurs. Share on ...

Its interpretation is very straightforward: ‘Circumcision of HIV-infected men did not reduce HIV transmission to female partners over 24 months; longer-term effects could not be assessed.